This inventor holds 1 USPTO granted patent. Top assignee: University of Utah Research Foundation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Ying Li - Innovator in Neurofibromatosis Research
Introduction
Ying Li is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of genetics, particularly in understanding neurofibromatosis type 1. His work focuses on the somatic mutations of the NF1 gene, which play a crucial role in human tumors.
Latest Patents
Ying Li holds a patent titled "Somatic mutations in neurofibromatosis type 1 gene in human tumors." This invention is directed to identifying somatic mutations of the NF1 gene found in human tumors. Additionally, it includes methods for screening individuals to determine the presence of these mutations. The invention also proposes a method for treating patients with tumors that have somatic mutations in the NF1 gene by restoring the natural regulation of ras proteins.
Career Highlights
Ying Li is affiliated with the University of Utah Research Foundation, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and genetic screening.
Collaborations
Ying Li has collaborated with notable colleagues, including Raymond L. White and Richard M. Cawthon. Their combined expertise enhances the research efforts in the field of neurofibromatosis.
Conclusion
Ying Li's innovative work in the study of neurofibromatosis type 1 and his patent on somatic mutations of the NF1 gene highlight his contributions to medical research. His efforts pave the way for advancements in genetic screening and treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile